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Abstract
Some features found on chest computed tomography (CT), such as central tumor location, large pleural effusion,
and the absence of a pleural tail, and a patient age of less than 60 years, have been suggested to be useful in
predicting anaplastic lymphoma kinase (ALK) rearrangement in patients with non-small cell lung cancer (NSCLC).
A 68-year-old female patient with a history of gynecological treatment was found to have a cavitary mass in the
right lower lobe on an annual chest roentgenogram. The tumor was located in the peripheral area with a pleural
tail showing no pleural effusion. In addition, two pure ground-glass-opacity nodules (p-GGNs) in the right upper
lobe of the lung were detected on consecutive chest CT scans. The patient underwent right lower lobectomy,
partial resection of the right upper lobe, and hilar mediastinal lymph node dissection for complete resection of
each tumor. The pathological diagnosis was invasive mucinous adenocarcinoma with signet-ring cells for the
cavitary mass in the right lower lobe and invasive adenocarcinoma for the rest of the p-GGNs; subcarinal lymph
node metastasis was also detected. The ALK rearrangement was detected by fluorescence in situ hybridization
from the cavitary mass. The patient underwent four cycles of cisplatin and vinorelbine chemotherapy as standard
adjuvant chemotherapy for pStage III NSCLC. The ALK fusion gene status of NSCLC with atypical CT features should
also be investigated.
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Background
Several radiological features delineated by chest computed
tomography (CT) of non-small cell lung cancer (NSCLC)
have been reported to be associated with some utility in
detecting the gene mutation status, such as epidermal
growth factor receptor (EGFR) or anaplastic lymphoma
kinase (ALK) rearrangement. Certain features of a tumor
on chest CT, such as convergence, notch, and a pleural
tail, have been reported to have a significant association
with an EGFR or ALK fusion gene mutation [1–5]. With
regard to the mutation of the ALK fusion gene, the com-
bination of certain tumor features on chest CT, such as a
central tumor location, large pleural effusion, and the ab-
sence of a pleural tail, and a younger patient age (<60 years
old), were shown to have a significant relationship with
ALK rearrangement in patients with NSCLC [6]. In gen-
eral, larger squamous cell carcinomas often show cavita-
tion, and cavitary masses have been found in a number of
adenocarcinoma patients who had a poor prognosis [7].
We herein report a case of surgically resected lung
adenocarcinoma that presented as a cavitary mass har-
boring ALK fusion with rare radiological features.
Case presentation
A 68-year-old female was found to have a cavitary mass
on annual chest roentgenography in December 2015. She
had a history of treatment for cervical cancer in the uterus
in 2001 and had been followed up at our hospital without
recurrence. She was a never-smoker and had no signifi-
cant abnormalities on a physical examination except for
an abdominal scar related to the treatment for her cervical
cancer.
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Chest CT revealed a cavitary mass, approximately
4.3 cm in its maximum dimension, in the basal segment
of the right lower lobe of the lung (Fig. 1a). In addition,
we noted 2 pure ground-glass-opacity nodules (p-GGNs),
8 and 12 mm in their maximum dimensions. Retrospect-
ively, abdominal CT performed in 2008 occasionally re-
vealed a tiny nodule in the basal segment of the right
lower lobe adjacent to the visceral pleura on the dia-
phragm (Fig. 1b). No significant hilar or mediastinal
lymph node swelling was observed. fluorodeoxyglucose
positron emission tomography (FDG-PET) showed no ab-
normal accumulation except in the mass in the right lower
lobe. A biopsy of the tumor via fiber optic bronchoscopy
could not distinguish the cavitary mass from a metastatic
or primary tumor. The two p-GGNs were considered to
be multiple primary lung cancers. The patient underwent
video-assisted thoracoscopic right lower lobectomy, partial
resections for the two p-GGNs in the right upper lobe,
and systemic hilar mediastinal lymph node dissection
as curative intent resection. An analysis of the intraop-
erative frozen sections for the three tumors revealed
adenocarcinoma.
A pathological examination revealed the cavitary mass
in the right lower lobe to be invasive mucinous adeno-
carcinoma (60% acinar, 30% micropapillary, 10% papil-
lary growth pattern) with signet-ring cells (Fig. 1c).
Mediastinal lymph node metastasis was found in the
subcarinal lesion. The two p-GGNs were pathologically
different from the cavitary mass in the right lower lobe;
thus, the pathological diagnosis was multiple primary
NSCLC: pT2aN2M0 stage IIIA adenocarcinoma for the
cavitary mass in the right lower lobe and pT1aN0M0
stage IA adenocarcinoma for each p-GGN in the right
upper lobe. The patient received four cycles of cisplatin
and vinorelbine as adjuvant chemotherapy. In addition,
ALK rearrangement was detected by FISH from the
specimen obtained from the cavitary mass on the right
lower lobe. The postoperative course was uneventful,
and the patient is currently disease-free at 5 months post
operation.
Discussion
Previous reports have shown that some CT features are
significantly associated with the ALK fusion gene [2–5].
Yamamoto et al. reported that three CT features, namely
a central tumor location, large pleural effusion, and the
absence of pleural tail, with a patient age of less than
60 years, were good predictors of the presence of the
ALK fusion gene in cases of NSCLC [6]. In addition,
Yamamoto et al. attempted to predict the presence of
the ALK fusion gene using those three CT features and
the age of patients and revealed a sensitivity and specifi-
city of 89.4 and 100.0%, respectively, for the presence of
the ALK fusion gene in certain cohorts of patients. How-
ever, the equation failed to demonstrate the presence of
the ALK fusion gene in our patient in the present report.
Retrospectively, a tiny nodule was occasionally found in
the basal segment adjacent to the visceral pleura (the
peripheral area of the right lung on an abdominal CT
taken 8 years prior as a follow-up of cervical cancer of
the uterus; Fig. 1b). The present case therefore differed
with respect to the predictive factors for the presence of
the ALK gene fusion in the cavity formation in the
tumor, an initial tumor location in a peripheral site
Fig 1 a Chest cross-sectional computed tomography (CT) showing a cavitary mass in the S6 segment in the peripheral area with a pleural tail
and without pleural effusion. b An abdominal CT scan taken in 2008 occasionally showed a tiny nodule on the basal segment of the right lower
lobe adjacent to the visceral pleura on the diaphragm (arrow). c The results of a histological examination. Invasive mucinous adenocarcinoma
with signet-ring cells in an S6 tumor (hematoxylin and eosin staining, original magnification ×400)
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without pleural tail formation, and a patient age over
60 years old.
With regard to the pathological features of this case, the
permanent specimen showed invasive mucinous adeno-
carcinoma with signet-ring cells (Fig. 1c). Signet-ring cells
are a rare feature of primary lung adenocarcinoma [7]; the
presence of signet-ring-cell elements is significantly more
frequent in ALK+ lung cancer [8]. Given that the ALK
status of the patient was positive, these findings were con-
sistent with those of previous reports.
Conclusions
We report a case of NSCLC harboring ALK rearrangement
with uncommon radiological features. The ALK gene
status of NSCLC with atypical CT features should also
be investigated.
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